Disclosure Of Entity's Operating Segments [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
6
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
- NOK
- NOK
Profit (loss) before tax
16 417 NOK
20 315 NOK
Profit (loss)
16 417 NOK
16 417 NOK
- NOK
- NOK
- NOK
20 315 NOK
20 315 NOK
- NOK
Assets
31 215 NOK
44 050 NOK
Liabilities
7 762 NOK
5 008 NOK
Cash flows from (used in) operating activities
13 758 NOK
14 970 NOK
Cash flows from (used in) investing activities
- NOK
- NOK
Cash flows from (used in) financing activities
357,000 NOK
442,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.